Federal Circuit Upholds Injunction Vs. Teva, Ranbaxy
Pfizer and its subsidiary Warner Lambert Company LLC sued Teva and Ranbaxy in January in response to the companies’ combined launch of the generic product. The suit was filed in U.S. District Court for the District of New Jersey.
In an early victory for Pfizer, the generic Accupril, with the active ingredient...
To view the full article, register now.